About RAA

Synexus Expands Global Capability and Enters US Market with Acquisition of Research Across America

We are delighted to announce that Research Across America has been acquired by Synexus; together we are the world’s leading Site Management Organization (SMO). We are dedicated to the recruitment and management of clinical trials across the globe on behalf of our customers.

Synexus has been working with customers for over 24 years and already has dedicated research sites spanning ten countries. Synexus was keen to find a US partner to offer service in the world’s most significant development market. We are pleased to say RAA was selected on the basis of our expertise, credentials and experience in the clinical trials market.

Your Research Across America team will operate under the Synexus name, but will continue to focus on the same areas of work whilst being able to expand our offering to you as a customer. We do not foresee any changes to your project/s and Kelly Walker, COO, will continue to lead the current RAA operations and Corrie Palm continues as Vice President, Business Development.

We are delighted to have become part of a truly patient focused and now global organization that can improve trial speed and efficiency for our customers.

About Synexus

Synexus® is the world’s leading Site Management Organization (SMO), dedicated to the recruitment and running of clinical trials at its own research sites across the globe on behalf of its pharmaceutical, biotech and CRO clients. Synexus operates a global network of dedicated research sites , focusing on cardiovascular, metabolic (diabetes and obesity), musculo skeletal, respiratory and CNS (dementia and pain) trials mainly in phase III. Visit www.synexus.com.

History of RAA

Research Across America was originally established by Jeffrey Adelglass M.D. Dr. Adelglass conducted clinical trials for many years from his clinical practice and found a need for establishing a separate location devoted strictly for research in 1989. During that time, we have grown from a single location to multiple sites across the United States with a devoted staff of clinical trial specialists who have managed nearly 2,000 clinical studies.

Research Across America is an Independent Site Alliance-ISA, not an SMO; the sites are under one corporate umbrella for benefits purposes but they have the flexibility of negotiating their own contracts and budgets, and have their own coordinators and site managers. Our network of outstanding board-certified physicians investigators and professional research coordinators are committed to providing superior service to our patients and sponsor companies with which we work. Guided by our in-house quality assurance management, timely and accurate collection and completion of data is provided under the strictest ICH/GCP requirements.

Research Across America is proud to work with many of the major global pharmaceutical companies and contract research organization (CROs) in the following areas of research.

Aesthetics

Allergy/Asthma

Cardiology (cholesterol/hypertension)

Dermatology

Ear, Nose & Throat

Endocrinology (Obesity/Diabetes)

Family & Internal Medicine

Gastroenterology

Gynecology

Infectious Disease

Migraines/Headaches

Nutraceuticals

Ophthalmology

Osteoarthritis

Pain Management

Pediatrics

Psychiatry

Rx-to-OTC Switch

Smoking Cessation

Urology

Vaccines

Volunteer Info

Benefits of Being A Research Volunteer

The possible benefits of study participation may include:

Study-related exams at no cost

Study medication (possibly placebo)

Reimbursement for time and travel expenses for most studies

Contributing to the development of new therapies and learning more about a medical condition and treatment options

Volunteer Eligibility

Participant eligibility in a clinical trial is based on inclusion/exclusion criteria documented in a clinical trial protocol. Some studies require a person to have a specific condition with specific symptoms, while others are for healthy individuals interested in preventative care. An initial phone screening evaluates individuals to see if their health history might be a good match for a study. Then a screening visit is made for the patient to be evaluated at the research site by a study coordinator and physician to confirm enrollment eligibility.

Phases of Medical Research

Medical research studies are classified into a few different phases. Each phase has a different focus, but all work towards the goal of finding a new or improved treatment. These phases include:

Phase 1 Clinical Studies – In Phase 1, a new drug or treatment is tested on a small group of people — usually about 20 to 80. The new treatment has already been tested for safety in the lab and in animals, and has shown to have good potential for helping people. It has also been submitted to a government regulatory agency and approved for use in human testing.The purpose of this phase is to find out if the treatment is safe for humans, and if so, how much should be given and how. Those who participate in this phase are watched very closely (usually requires overnight stays), and the researchers record and study any side effects that happen after taking the study drug.

Phase 2 Research Studies – In Phase 2, a larger group of people receives the drug or treatment. There can also be a placebo group that does not receive the new treatment. The main purpose of this phase is to find out whether or not the new treatment is actually effective in treating the patient’s disease or medical condition. The safety of the drug or treatment continues to be studied in this phase, and any side effects are carefully reviewed.

Phase 3 Studies – A large group of people are involved in Phase 3 studies. Those who participate in Phase 3 are usually randomly assigned to different groups. In one group, up to a few thousand people will receive the new treatment.Another group receives the standard treatment for the same medical condition, or receives a placebo. This is called the “control” group. The side effects and treatment success in people receiving the new treatment are compared to those in the control group. This helps the researches know if the new treatment is really safer and more effective.During this phase, researchers will continue to collect information about side effects, and also study how often the condition returns and the effects of the treatment on the patient’s quality and length of life.After Phase 3 studies are completed, a medicine can be submitted to the government for final approval.

Phase 4 Research Studies – Once a new treatment has been approved, there may be additional clinical studies performed. These are called Phase 4 studies. These studies are conducted for a number of reasons. One of these is to find out how effective the treatment is in different groups of people — such as those of the same race or age group. Another is to see if the treatment can be more effective if administered in a different fashion. For example, a pill can be changed to a topical cream for a more direct approach to muscle/joint pain. Information is also gathered about long-term effects of the treatment.

IRB Protections

Each clinical trial is approved for suitability by an Institutional Review Board (IRB) comprised of professionals from the fields of medicine, religion, law, and education. The IRB’s function serves to protect the safety and rights of volunteers in clinical trials.

HIPAA Regulations

New privacy regulations ensure privacy protections for patients by protecting medical records and other individually identifiable health information, whether it is on paper, in computers or communicated orally. To learn more, visit www.hipaa.com.

Research Across America is conducting a clinical research study of an investigational medication for individuals with heavy menstrual bleeding associated with uterine fibroids. You may qualify to participate if you:

Are premenopausal 18 – 50 years old

Heavy Periods

Have uterine fibroids

Have monthly periods

Qualified study participants will received study-related care and study medication at no cost. Compensation up to $1225 may be available for study-related time and travel.

Call for more information 972-4-DOCTOR (972-436-2867)

About Dr. Adelglass

Research Across America (RAA) is physician-owned and operated. Founded by Dr. Jeffery Adelglass in 1989, his renown presence in the Dallas community with his private ENT practice helped to attract other specialty research physicians who shared Dr. Adelglass’ passion to conduct clinical trials that will improve medications and expand treatment options. RAA has enjoyed the growth of our Principal Investigative team, to include doctors representing nearly every major medical therapeutic area at multiple research sites across the country, including: Dallas, TX; Katy/Houston, TX; El Paso, TX; Santa Ana, CA; Reading/Lancaster, PA; and Manhattan, NY. This has helped RAA expand its study capabilities portfolio and allowed us to work with almost every major pharmaceutical company.

Site Map

[pagelist, exclude=”315, 21″]

Privacy Policy

At Research Across America, we are committed to being the premier site management organization for clinical trials for new drug development. To that end, we have the utmost respect for your privacy and want you to be confident that we will not use any information given to us for purposes other than those we communicate to you at the time it is given. To demonstrate our commitment to fair information practices, we have adopted leading industry privacy guidelines set forth below.

Gathering Personal and Organization Information

Research Across America does not generally gather any personal information about you or your organization when you visit this site. However, when potential study participants search for information about Research Across America’s clinical trials, certain information will be requested of you in some of our forms pages. We collect the data from you to see if you will qualify for future studies.

Research Across America may also ask for certain contact information (name, address, etc.) of potential sponsors, clinical research organizations and investigators. Information you supply to Research Across America is voluntary and will relate to the relationship Research Across America has with you or your organization and will be only requested to the extent it is necessary to provide the services you have requested. Research Across America may also log IP addresses to analyze trends, administer the site, track visitor movements, and gather broad demographic information for aggregate use; provided that such use is for internal purposes of Research Across America or its affiliates or partners only.

Research Across America is the sole owner of the information collected on this site. We will not distribute, sell, or rent your name or email address or any other personal or organizational information about you to any third party without your consent.

Using Personal or Organizational Information

If you do choose to give us personal information or information about your organization, we will let you know how it will be used. For instance, we may make it easier for you to interact with us by not having to enter your name or email address more than once when you access or sign up to receive certain information. We may also use the data to make the site more relevant to you or to notify you of information and offers you may be interested in. In the process of administering our site, we are responsible for maintaining and updating any changes you make to your personal profile.

Sharing Personal or Organizational Information

Your profile information, such as your name, title, address, etc., may be used to create personalized content, offers, services, and advertising to be used only by Research Across America. Research Across America will always make sure that you can “opt-out” of services like this if you prefer. However, Research Across America may share aggregate, non-personal, non-individual information collectively with its marketing partners for research purposes only. We will not share individual information regarding the transactions on our site or the specific content of those transactions with any third party.

Cookies

A cookie is a piece of data stored on the user’s hard drive containing information about the user. Some Research Across America pages may use cookies or other technologies so that we can better serve you when you return to our site. Usage of a cookie is in no way linked to any personally identifiable information while on our site – instead they enable us to track and target your interests to better enhance your experience on our site. You can set your browser to notify you when you receive a cookie, giving you the opportunity to either accept or deny it. If you reject the cookie, you may still use our site; however, you will be limited in some areas.

Consent

Research Across America may use and share visitor information in ways related to those above. We reserve the right to disclose any and all pertinent customer information to law enforcement or other government officials, as we believe necessary or appropriate.

Security

To prevent unauthorized access or disclosure of visitors’ information, maintain data accuracy, and ensure the appropriate use of the information, Research Across America has put in place reasonable physical, electronic, and managerial procedures to protect the information we collect from the site. The highest security procedures and encryption technologies are in place to protect any collected information from loss, misuse, or alteration.

Your Acceptance

By using the Research Across America site, you signify your understanding and acceptance of this Privacy Statement. If we decide to change our privacy policy, we will post those changes on www.researchacrossamerica.com so you are always aware of what information we collect, how we use it, and under which circumstances, if any, we disclose it. Your continued usage of the Research Across America site following the posting of additions and/or changes to this Privacy Statement means you accept those changes.

Research Across America, all titles, characters, names, graphics and icons are service marks, trademarks, and/or trade dress of Research Across America. All other trademarks, product names and company names or logos herein are the property of their respective owners.

Disclaimer

This site and its contents are provided on an “as is” basis without representations or warranties of any kind with respect to this site or its contents. Research Across America disclaims all such representations and warranties, including for example warranties of merchantability and fitness for a particular purpose. In addition, Research Across America does not represent or warrant that the information accessible via this site is accurate, complete, or current. Content is subject to change without notice.

Except as specifically stated on this site, neither Research Across America nor any of its directors, employees, or other representatives will be liable for damages arising out of or in connection with the use of this site. This a comprehensive limitation of liability that applies to all damages of any kind, including (without limitation) compensatory, direct, indirect or consequential damages, loss of data, income or profit, loss of or damage to property, and claims of third parties.

Research Across America often obtains news items and statistical data from various sources. Accordingly, the information displayed on the site is not guaranteed to be 100% accurate and the source referenced should be considered the authoritative source.

Links

The Research Across America site contains links to third-party sites which are not under the control of Research Across America. Research Across America makes no representations whatsoever about any other site to which you may have access through the Research Across America site. When you access a non- Research Across America site, you do so at your own risk and Research Across America is not responsible for the accuracy or reliability of any information, data, opinions, advice, or statements made on these sites. Research Across America provides these links merely as a convenience and the inclusion of such links does not imply that Research Across America endorses or accepts any responsibility for the content or uses of such sites.

Contact Us

Synexus/RAA Acquisition:

We are delighted to announce that Research Across America has been acquired by Synexus; together we are the world’s leading Site Management Organization (SMO). Your Research Across America team will operate under the Synexus name, but will continue to focus on the same areas of work whilst being able to expand our offering to you as a customer. We do not foresee any changes to your project/s and Kelly Walker, COO, continues to lead the current RAA operations and Corrie Palm continues as Vice President, Business Development.

The Synexus dedicated site model of patient recruitment, trial conduct and patient retention improves the speed and efficiency of clinical trials on behalf of Pharma, Biotech and CRO customers. Dedicated sites benefit from its investment in best-in-class quality SOPs, access to scientific advisory boards for key therapeutic areas and a wide network of KOLs that provide valuable insight to customers.

Request Information

Your Name (required)

Your Email (required)

Your Phone Number (required)

Sponsor/CROPatient

If Sponsor/CRO, please list your company or organization:

**By submitting this form you consent and agree to receive emails and phone calls about our research studies and join our database.

Employment Opportunities

Sponsor Information

Synexus/RAA Acquisition:

We are delighted to announce that Research Across America has been acquired by Synexus; together we are the world’s leading Site Management Organization (SMO). Your Research Across America team will operate under the Synexus name, but will continue to focus on the same areas of work whilst being able to expand our offering to you as a customer. We do not foresee any changes to your project/s and Kelly Walker, COO, continues to lead the current RAA operations and Corrie Palm continues as Vice President, Business Development.

The Synexus dedicated site model of patient recruitment, trial conduct and patient retention improves the speed and efficiency of clinical trials on behalf of Pharma, Biotech and CRO customers. Dedicated sites benefit from its investment in best-in-class quality SOPs, access to scientific advisory boards for key therapeutic areas and a wide network of KOLs that provide valuable insight to customers.

Request Information

Your Name (required)

Your Email (required)

Your Phone Number (required)

Sponsor/CROPatient

If Sponsor/CRO, please list your company or organization:

**By submitting this form you consent and agree to receive emails and phone calls about our research studies and join our database.

STAFF INFORMATION

At Research Across America, the only thing that outshines our facilities is our STAFF. Our clinical trials are performed in accordance with ICH-GCP and FDA standards. Our experienced research team consists of:

Patient Information

Research Across America is currently conducting a variety of research studies throughout the United States. Research studies play a vital role in field of medical science; at Research Across America all studies are conducted under the direction of Dr. Jeffrey Adelglass and his highly trained staff. There are studies for people of all ages, races and genders; the specific requirements for each study and study location can be found by calling our research call center. If you see a study you are interested in participating in please contact the office conducting that study to find out if you qualify.

Research Across America is actively seeking volunteers for studies in a number of therapeutic areas.

Here are a few of our current medical studies:

Rosacea Research StudyClick ‘show’ below to display details of the study.

If you suffer from Rosacea (Papulopustular), you may qualify to participate in a clinical research study of an investigational topical study drug.
• Receive Study-Related Investigational drug
• Participants may receive compensation for Time & Travel

Birth Control Research StudyClick ‘show’ below to display details of the study.

This is an open label research study to evaluate an investigational birth control pill for women. All study participants receive the study drug at no cost for one year. This study is approximately 14 months, including a 4-6 week screening period, a one year period and a 2 week follow up period. There are 6 visits which span over about 3 months apart, with compensation up to $600 for time and travel. Participants will be required to undergo a physical exam, including a pap smear.
• Women 18 t0 50 years of age and overall healthy
• Not planning to become pregnant for the next 14 months
• Are at risk of becoming pregnant and not planning to use other oral contraceptive methods

We are currently conducting a research study for an investigational medication for type 2 diabetes. If you are 18 years of age or older and have been diagnosed with diabetes, you may qualify to participate in this clinical research study. Qualified participants may receive at no cost:

Healthy Volunteer Vaccine Research Study – This study utilizes a vaccine that is approved for active immunization for the prevention of disease caused by anthrax and an approved antibiotic to evaluate the response when administered together. You would randomly be assigned to one of 3 different arms of the study which each entail a different number of office visits, some of which could be overnight stays.

• Ages 18 to 45 and overall healthy.
• No one will be exposed to anthrax as part of this study, and no one can get anthrax from the study drugs.
• Study visits range from 6 to 16 visits; time & travel reimbursement range is $425 to $2075.

Vaginal Dryness Research Study – This research study evaluates an investigational vaginal gel for the pain and irritation of vaginal dryness in postmenopausal women at least 35 years of age. There are 6 study visits over 12 weeks with lab work, including a possible mammogram, provided at no cost. Compensation up to $450.00 is provided for time and travel if you qualify.

This research study evaluates an Investigational injectable medication for weight loss as compared to placebo (inactive substance).

• 18 to 65 years of age, non-diabetic and overall healthy, with a BMI higher than 35.
• Must also be willing to follow American Heart Association standard diet
• 11 office visits over 7 months, with up to $825.00 for time & travel reimbursement.

Meningococcal Vaccine Research Study – What is Meningococcal disease type B (MnB)? Meningococcal disease type B (MnB) is caused by a certain type of bacteria that can make you very sick. No vaccine to prevent MnB is currently available. Young people (ages 10-25) may be eligible to take part in a clinical trial* to test an investigational† vaccine for MnB.

A clinical trial is a carefully managed study done by doctors to learn more about potential new medicines and treatments.
† An investigational vaccine is an unapproved vaccine that is being tested in a clinical trial.

Actinic Keratosis Research Study – Do you have sun spots or age spots that are dry or rough on your face or scalp? It may be a common skin condition called Actinic Keratosis (AK). This research study evaluates an investigational topical medication for this condition. The study has 5 visits over approximately 14 weeks and compensates up to $375.00 for time and travel. To be eligible you must be at least 18 years of age and have Actinic Keratosis lesions on the face or balding scalp.

Diabetes Type 2 Research Study – This research study provides an investigational oral medication for Type II Diabetics who have normal to severely impaired kidney function with an HBA1C level between 7.0 & 11.0. The study requires two consecutive overnight stays , with up to $1,275 provided for time & travel. To qualify, you must be 18 to 79 years of age with a diagnosis of Diabetes Type II and not taking insulin more than twice a day (other criteria apply). Complimentary Kidney Function & HBA1C tests are provided to potential study participants to determine eligibility.

Are frequent nightlytrips to the bathroom leaving you exhausted? Nocturia, or frequent urination at night, is a common urological disorder in adults. It typically results in a loss of sleep. Over time, this can lead to fatigue, memory deficits, depression and other issues. In many people the effect of nocturia can compromise their quality of life during daytime hours. Help may be available for people with nocturia. A clinical trial is currently underway to test the effectiveness of a medication to treat nocturia. You may be eligible to participate in this study if you meet the following criteria:

• Are male
• Are age 55 or older
• Have a history of nocturia2-5 voids per night
• Persistent nocturia despite appropriate lifestyle advice (e.g. evening fluid restriction)
• Are generally well

All trial-related visits, testing and study medication or placebo will be provided to participants at no cost. Compensation for time and travel may be available.

Swimmer’s Ear Research Study – You don’t have to be a swimmer to get swimmer’s ear. If you are experiencing pain, itching or swelling of the outer ear, you may have a type of ear infection called acute otitis externa (AOE), also known as swimmer’s ear. While swimmer’s ear is most commonly caused by swimming, it can also occur from the use of hearing aids, headphones (or “earbuds”) and various types of hearing protection. Local doctors in your area are conducting a research study for effectiveness of investigational antibiotic drops for acute otitis externa (AOE). Individuals 6 months of age or older with swimmer’s ear may be eligible to participate.

Cold Sore/Fever Blister Research Study – If you have experienced 3 fever blisters/cold sores on or around the mouth in the last year, you may be eligible to participate in this medical research study evaluating an investigational topical lotion. The study is for those 18 years of age and older who get frequent cold sores and are otherwise healthy. Compensation is available for time and travel if you qualify.

Athlete’s Foot Research Study – If you have been experiencing red, scaly, flaky, and itchy skin between your toes, you might have athlete’s foot, or tinea pedis. Those 18 and older with a suspected case of athlete’s foot might qualify for a research study that evaluates an investigational topical gel as compared to placebo (substance with no medication). The study lasts 6 weeks and has up to 3 office visits and one telephone call, with compensation up to $225.00 for time and travel if you qualify.

Facial Acne Research Study – This acne research study is for those 12 to 40 years of age (those 17 and younger must have a parent/legal guardian to sign consent) who have moderate to severe facial acne. The purpose of this study is to evaluate 2 different study gels versus placebo. Participants have 4 visits over 12 weeks and are compensated up to $300.00 for time and travel.

Melanoma Study – Are you at high risk for recurrence? If so, and you are between the ages of 18 and 75 years old, you may qualify to participate in a clinical research study at Research Across America to determine the safety and effectiveness of an investigational treatment vaccine. Qualified participants will receive at no cost:

Major Depression Study – Are you feeling persistently sad or anxious? Feeling guilty, hopeless, worthless? Have you lost interest in usual activities, including sex? Do you have trouble sleeping or concentrating? If these symptoms of depression persistently interfere with your daily life, you may qualify for a medical research study. This study is for those 18 to 65 years old who have a diagnosis of Major Depressive Disorder. It requires 7 office visits, compensation for time and travel may be available.

Bipolar Type I Research Study – A research study is enrolling those 18 and older with a history of Bipolar Type I for an approved medication for bipolar type 1, to evaluate its effectiveness in treating recurrent acute Manic/Mixed Episodes. Everyone who qualifies to participate receives the study medication at some point during the trial. Psychological evaluations, drug screens and exams are provided at no cost, with compensation of $75 per visit available for time and travel. You may also be eligible for assistance in receiving your anti-psychotic medication immediately following the study, if all requirements of the study are followed.

ADHD Research Study – Is your child aged 13-17 diagnosed with ADHD? You may be eligible to participate in a research study of an investigational medication. Symptoms of ADHD include difficulty remembering information, difficulty concentrating, trouble organizing or completing tasks, and procrastination. Qualified participants may receive study-related psychological evaluation(s) and may also receive compensation for time and travel.

Pediatric Seasonal Allergy Research Study – This study is for children ages 6 to 11 years old who suffer from Seasonal Allergic Rhinitis (SAR) for the last year. The purpose is to evaluate an investigational nasal spray compared to placebo for allergy symptoms. The study could be up to 2 months long and have 5 office visits and one telephone call. Reimbursement for time and travel will be provided for those who qualify.

BPH – Benign Prostatic Hyperplasia Study – This research study is for men ages 45 and over who have had a diagnosis of BPH at least 1 year ago. Symptoms of BPH include night time and frequent urination. The study evaluates an investigational medication that has shown promise in lowering the BPH score. Participants would come to 10 office visits over 1 year and be compensated up to $750.00 for time and travel. Everyone in the trial who wants to will receive the investigational drug either during the trial or at the end of it.

Influenza Research Study – At the first sign of flu symptoms, you may qualify for a medical research study evaluating an investigational medication for flu symptoms. You must be experiencing a fever of at least 100.4 and be experiencing flu symptoms (for example: nasal congestion, coughing, sneezing, chills, fatigue). The study requires 4 office visits over 28 days. Compensation up to $240 is available for time and travel.

About RAA

Synexus Expands Global Capability and Enters US Market with Acquisition of Research Across America

We are delighted to announce that Research Across America has been acquired by Synexus; together we are the world’s leading Site Management Organization (SMO). We are dedicated to the recruitment and management of clinical trials across the globe on behalf of our customers.

Synexus has been working with customers for over 24 years and already has dedicated research sites spanning ten countries. Synexus was keen to find a US partner to offer service in the world’s most significant development market. We are pleased to say RAA was selected on the basis of our expertise, credentials and experience in the clinical trials market.

Your Research Across America team will operate under the Synexus name, but will continue to focus on the same areas of work whilst being able to expand our offering to you as a customer. We do not foresee any changes to your project/s and Kelly Walker, COO, will continue to lead the current RAA operations and Corrie Palm continues as Vice President, Business Development.

We are delighted to have become part of a truly patient focused and now global organization that can improve trial speed and efficiency for our customers.

About Synexus

Synexus® is the world’s leading Site Management Organization (SMO), dedicated to the recruitment and running of clinical trials at its own research sites across the globe on behalf of its pharmaceutical, biotech and CRO clients. Synexus operates a global network of dedicated research sites , focusing on cardiovascular, metabolic (diabetes and obesity), musculo skeletal, respiratory and CNS (dementia and pain) trials mainly in phase III. Visit www.synexus.com.

History of RAA

Research Across America was originally established by Jeffrey Adelglass M.D. Dr. Adelglass conducted clinical trials for many years from his clinical practice and found a need for establishing a separate location devoted strictly for research in 1989. During that time, we have grown from a single location to multiple sites across the United States with a devoted staff of clinical trial specialists who have managed nearly 2,000 clinical studies.

Research Across America is an Independent Site Alliance-ISA, not an SMO; the sites are under one corporate umbrella for benefits purposes but they have the flexibility of negotiating their own contracts and budgets, and have their own coordinators and site managers. Our network of outstanding board-certified physicians investigators and professional research coordinators are committed to providing superior service to our patients and sponsor companies with which we work. Guided by our in-house quality assurance management, timely and accurate collection and completion of data is provided under the strictest ICH/GCP requirements.

Research Across America is proud to work with many of the major global pharmaceutical companies and contract research organization (CROs) in the following areas of research.

Aesthetics

Allergy/Asthma

Cardiology (cholesterol/hypertension)

Dermatology

Ear, Nose & Throat

Endocrinology (Obesity/Diabetes)

Family & Internal Medicine

Gastroenterology

Gynecology

Infectious Disease

Migraines/Headaches

Nutraceuticals

Ophthalmology

Osteoarthritis

Pain Management

Pediatrics

Psychiatry

Rx-to-OTC Switch

Smoking Cessation

Urology

Vaccines

Volunteer Info

Benefits of Being A Research Volunteer

The possible benefits of study participation may include:

Study-related exams at no cost

Study medication (possibly placebo)

Reimbursement for time and travel expenses for most studies

Contributing to the development of new therapies and learning more about a medical condition and treatment options

Volunteer Eligibility

Participant eligibility in a clinical trial is based on inclusion/exclusion criteria documented in a clinical trial protocol. Some studies require a person to have a specific condition with specific symptoms, while others are for healthy individuals interested in preventative care. An initial phone screening evaluates individuals to see if their health history might be a good match for a study. Then a screening visit is made for the patient to be evaluated at the research site by a study coordinator and physician to confirm enrollment eligibility.

Phases of Medical Research

Medical research studies are classified into a few different phases. Each phase has a different focus, but all work towards the goal of finding a new or improved treatment. These phases include:

Phase 1 Clinical Studies – In Phase 1, a new drug or treatment is tested on a small group of people — usually about 20 to 80. The new treatment has already been tested for safety in the lab and in animals, and has shown to have good potential for helping people. It has also been submitted to a government regulatory agency and approved for use in human testing.The purpose of this phase is to find out if the treatment is safe for humans, and if so, how much should be given and how. Those who participate in this phase are watched very closely (usually requires overnight stays), and the researchers record and study any side effects that happen after taking the study drug.

Phase 2 Research Studies – In Phase 2, a larger group of people receives the drug or treatment. There can also be a placebo group that does not receive the new treatment. The main purpose of this phase is to find out whether or not the new treatment is actually effective in treating the patient’s disease or medical condition. The safety of the drug or treatment continues to be studied in this phase, and any side effects are carefully reviewed.

Phase 3 Studies – A large group of people are involved in Phase 3 studies. Those who participate in Phase 3 are usually randomly assigned to different groups. In one group, up to a few thousand people will receive the new treatment.Another group receives the standard treatment for the same medical condition, or receives a placebo. This is called the “control” group. The side effects and treatment success in people receiving the new treatment are compared to those in the control group. This helps the researches know if the new treatment is really safer and more effective.During this phase, researchers will continue to collect information about side effects, and also study how often the condition returns and the effects of the treatment on the patient’s quality and length of life.After Phase 3 studies are completed, a medicine can be submitted to the government for final approval.

Phase 4 Research Studies – Once a new treatment has been approved, there may be additional clinical studies performed. These are called Phase 4 studies. These studies are conducted for a number of reasons. One of these is to find out how effective the treatment is in different groups of people — such as those of the same race or age group. Another is to see if the treatment can be more effective if administered in a different fashion. For example, a pill can be changed to a topical cream for a more direct approach to muscle/joint pain. Information is also gathered about long-term effects of the treatment.

IRB Protections

Each clinical trial is approved for suitability by an Institutional Review Board (IRB) comprised of professionals from the fields of medicine, religion, law, and education. The IRB’s function serves to protect the safety and rights of volunteers in clinical trials.

HIPAA Regulations

New privacy regulations ensure privacy protections for patients by protecting medical records and other individually identifiable health information, whether it is on paper, in computers or communicated orally. To learn more, visit www.hipaa.com.

Research Across America is conducting a clinical research study of an investigational medication for individuals with heavy menstrual bleeding associated with uterine fibroids. You may qualify to participate if you:

Are premenopausal 18 – 50 years old

Heavy Periods

Have uterine fibroids

Have monthly periods

Qualified study participants will received study-related care and study medication at no cost. Compensation up to $1225 may be available for study-related time and travel.

Call for more information 972-4-DOCTOR (972-436-2867)

About Dr. Adelglass

Research Across America (RAA) is physician-owned and operated. Founded by Dr. Jeffery Adelglass in 1989, his renown presence in the Dallas community with his private ENT practice helped to attract other specialty research physicians who shared Dr. Adelglass’ passion to conduct clinical trials that will improve medications and expand treatment options. RAA has enjoyed the growth of our Principal Investigative team, to include doctors representing nearly every major medical therapeutic area at multiple research sites across the country, including: Dallas, TX; Katy/Houston, TX; El Paso, TX; Santa Ana, CA; Reading/Lancaster, PA; and Manhattan, NY. This has helped RAA expand its study capabilities portfolio and allowed us to work with almost every major pharmaceutical company.

Site Map

[pagelist, exclude=”315, 21″]

Privacy Policy

At Research Across America, we are committed to being the premier site management organization for clinical trials for new drug development. To that end, we have the utmost respect for your privacy and want you to be confident that we will not use any information given to us for purposes other than those we communicate to you at the time it is given. To demonstrate our commitment to fair information practices, we have adopted leading industry privacy guidelines set forth below.

Gathering Personal and Organization Information

Research Across America does not generally gather any personal information about you or your organization when you visit this site. However, when potential study participants search for information about Research Across America’s clinical trials, certain information will be requested of you in some of our forms pages. We collect the data from you to see if you will qualify for future studies.

Research Across America may also ask for certain contact information (name, address, etc.) of potential sponsors, clinical research organizations and investigators. Information you supply to Research Across America is voluntary and will relate to the relationship Research Across America has with you or your organization and will be only requested to the extent it is necessary to provide the services you have requested. Research Across America may also log IP addresses to analyze trends, administer the site, track visitor movements, and gather broad demographic information for aggregate use; provided that such use is for internal purposes of Research Across America or its affiliates or partners only.

Research Across America is the sole owner of the information collected on this site. We will not distribute, sell, or rent your name or email address or any other personal or organizational information about you to any third party without your consent.

Using Personal or Organizational Information

If you do choose to give us personal information or information about your organization, we will let you know how it will be used. For instance, we may make it easier for you to interact with us by not having to enter your name or email address more than once when you access or sign up to receive certain information. We may also use the data to make the site more relevant to you or to notify you of information and offers you may be interested in. In the process of administering our site, we are responsible for maintaining and updating any changes you make to your personal profile.

Sharing Personal or Organizational Information

Your profile information, such as your name, title, address, etc., may be used to create personalized content, offers, services, and advertising to be used only by Research Across America. Research Across America will always make sure that you can “opt-out” of services like this if you prefer. However, Research Across America may share aggregate, non-personal, non-individual information collectively with its marketing partners for research purposes only. We will not share individual information regarding the transactions on our site or the specific content of those transactions with any third party.

Cookies

A cookie is a piece of data stored on the user’s hard drive containing information about the user. Some Research Across America pages may use cookies or other technologies so that we can better serve you when you return to our site. Usage of a cookie is in no way linked to any personally identifiable information while on our site – instead they enable us to track and target your interests to better enhance your experience on our site. You can set your browser to notify you when you receive a cookie, giving you the opportunity to either accept or deny it. If you reject the cookie, you may still use our site; however, you will be limited in some areas.

Consent

Research Across America may use and share visitor information in ways related to those above. We reserve the right to disclose any and all pertinent customer information to law enforcement or other government officials, as we believe necessary or appropriate.

Security

To prevent unauthorized access or disclosure of visitors’ information, maintain data accuracy, and ensure the appropriate use of the information, Research Across America has put in place reasonable physical, electronic, and managerial procedures to protect the information we collect from the site. The highest security procedures and encryption technologies are in place to protect any collected information from loss, misuse, or alteration.

Your Acceptance

By using the Research Across America site, you signify your understanding and acceptance of this Privacy Statement. If we decide to change our privacy policy, we will post those changes on www.researchacrossamerica.com so you are always aware of what information we collect, how we use it, and under which circumstances, if any, we disclose it. Your continued usage of the Research Across America site following the posting of additions and/or changes to this Privacy Statement means you accept those changes.

Research Across America, all titles, characters, names, graphics and icons are service marks, trademarks, and/or trade dress of Research Across America. All other trademarks, product names and company names or logos herein are the property of their respective owners.

Disclaimer

This site and its contents are provided on an “as is” basis without representations or warranties of any kind with respect to this site or its contents. Research Across America disclaims all such representations and warranties, including for example warranties of merchantability and fitness for a particular purpose. In addition, Research Across America does not represent or warrant that the information accessible via this site is accurate, complete, or current. Content is subject to change without notice.

Except as specifically stated on this site, neither Research Across America nor any of its directors, employees, or other representatives will be liable for damages arising out of or in connection with the use of this site. This a comprehensive limitation of liability that applies to all damages of any kind, including (without limitation) compensatory, direct, indirect or consequential damages, loss of data, income or profit, loss of or damage to property, and claims of third parties.

Research Across America often obtains news items and statistical data from various sources. Accordingly, the information displayed on the site is not guaranteed to be 100% accurate and the source referenced should be considered the authoritative source.

Links

The Research Across America site contains links to third-party sites which are not under the control of Research Across America. Research Across America makes no representations whatsoever about any other site to which you may have access through the Research Across America site. When you access a non- Research Across America site, you do so at your own risk and Research Across America is not responsible for the accuracy or reliability of any information, data, opinions, advice, or statements made on these sites. Research Across America provides these links merely as a convenience and the inclusion of such links does not imply that Research Across America endorses or accepts any responsibility for the content or uses of such sites.

Contact Us

Synexus/RAA Acquisition:

We are delighted to announce that Research Across America has been acquired by Synexus; together we are the world’s leading Site Management Organization (SMO). Your Research Across America team will operate under the Synexus name, but will continue to focus on the same areas of work whilst being able to expand our offering to you as a customer. We do not foresee any changes to your project/s and Kelly Walker, COO, continues to lead the current RAA operations and Corrie Palm continues as Vice President, Business Development.

The Synexus dedicated site model of patient recruitment, trial conduct and patient retention improves the speed and efficiency of clinical trials on behalf of Pharma, Biotech and CRO customers. Dedicated sites benefit from its investment in best-in-class quality SOPs, access to scientific advisory boards for key therapeutic areas and a wide network of KOLs that provide valuable insight to customers.

Request Information

Your Name (required)

Your Email (required)

Your Phone Number (required)

Sponsor/CROPatient

If Sponsor/CRO, please list your company or organization:

**By submitting this form you consent and agree to receive emails and phone calls about our research studies and join our database.

Employment Opportunities

Sponsor Information

Synexus/RAA Acquisition:

We are delighted to announce that Research Across America has been acquired by Synexus; together we are the world’s leading Site Management Organization (SMO). Your Research Across America team will operate under the Synexus name, but will continue to focus on the same areas of work whilst being able to expand our offering to you as a customer. We do not foresee any changes to your project/s and Kelly Walker, COO, continues to lead the current RAA operations and Corrie Palm continues as Vice President, Business Development.

The Synexus dedicated site model of patient recruitment, trial conduct and patient retention improves the speed and efficiency of clinical trials on behalf of Pharma, Biotech and CRO customers. Dedicated sites benefit from its investment in best-in-class quality SOPs, access to scientific advisory boards for key therapeutic areas and a wide network of KOLs that provide valuable insight to customers.

Request Information

Your Name (required)

Your Email (required)

Your Phone Number (required)

Sponsor/CROPatient

If Sponsor/CRO, please list your company or organization:

**By submitting this form you consent and agree to receive emails and phone calls about our research studies and join our database.

STAFF INFORMATION

At Research Across America, the only thing that outshines our facilities is our STAFF. Our clinical trials are performed in accordance with ICH-GCP and FDA standards. Our experienced research team consists of:

Patient Information

Research Across America is currently conducting a variety of research studies throughout the United States. Research studies play a vital role in field of medical science; at Research Across America all studies are conducted under the direction of Dr. Jeffrey Adelglass and his highly trained staff. There are studies for people of all ages, races and genders; the specific requirements for each study and study location can be found by calling our research call center. If you see a study you are interested in participating in please contact the office conducting that study to find out if you qualify.

Research Across America is actively seeking volunteers for studies in a number of therapeutic areas.

Here are a few of our current medical studies:

Rosacea Research StudyClick ‘show’ below to display details of the study.

If you suffer from Rosacea (Papulopustular), you may qualify to participate in a clinical research study of an investigational topical study drug.
• Receive Study-Related Investigational drug
• Participants may receive compensation for Time & Travel

Birth Control Research StudyClick ‘show’ below to display details of the study.

This is an open label research study to evaluate an investigational birth control pill for women. All study participants receive the study drug at no cost for one year. This study is approximately 14 months, including a 4-6 week screening period, a one year period and a 2 week follow up period. There are 6 visits which span over about 3 months apart, with compensation up to $600 for time and travel. Participants will be required to undergo a physical exam, including a pap smear.
• Women 18 t0 50 years of age and overall healthy
• Not planning to become pregnant for the next 14 months
• Are at risk of becoming pregnant and not planning to use other oral contraceptive methods

We are currently conducting a research study for an investigational medication for type 2 diabetes. If you are 18 years of age or older and have been diagnosed with diabetes, you may qualify to participate in this clinical research study. Qualified participants may receive at no cost:

Healthy Volunteer Vaccine Research Study – This study utilizes a vaccine that is approved for active immunization for the prevention of disease caused by anthrax and an approved antibiotic to evaluate the response when administered together. You would randomly be assigned to one of 3 different arms of the study which each entail a different number of office visits, some of which could be overnight stays.

• Ages 18 to 45 and overall healthy.
• No one will be exposed to anthrax as part of this study, and no one can get anthrax from the study drugs.
• Study visits range from 6 to 16 visits; time & travel reimbursement range is $425 to $2075.

Vaginal Dryness Research Study – This research study evaluates an investigational vaginal gel for the pain and irritation of vaginal dryness in postmenopausal women at least 35 years of age. There are 6 study visits over 12 weeks with lab work, including a possible mammogram, provided at no cost. Compensation up to $450.00 is provided for time and travel if you qualify.

This research study evaluates an Investigational injectable medication for weight loss as compared to placebo (inactive substance).

• 18 to 65 years of age, non-diabetic and overall healthy, with a BMI higher than 35.
• Must also be willing to follow American Heart Association standard diet
• 11 office visits over 7 months, with up to $825.00 for time & travel reimbursement.

Meningococcal Vaccine Research Study – What is Meningococcal disease type B (MnB)? Meningococcal disease type B (MnB) is caused by a certain type of bacteria that can make you very sick. No vaccine to prevent MnB is currently available. Young people (ages 10-25) may be eligible to take part in a clinical trial* to test an investigational† vaccine for MnB.

A clinical trial is a carefully managed study done by doctors to learn more about potential new medicines and treatments.
† An investigational vaccine is an unapproved vaccine that is being tested in a clinical trial.

Actinic Keratosis Research Study – Do you have sun spots or age spots that are dry or rough on your face or scalp? It may be a common skin condition called Actinic Keratosis (AK). This research study evaluates an investigational topical medication for this condition. The study has 5 visits over approximately 14 weeks and compensates up to $375.00 for time and travel. To be eligible you must be at least 18 years of age and have Actinic Keratosis lesions on the face or balding scalp.

Diabetes Type 2 Research Study – This research study provides an investigational oral medication for Type II Diabetics who have normal to severely impaired kidney function with an HBA1C level between 7.0 & 11.0. The study requires two consecutive overnight stays , with up to $1,275 provided for time & travel. To qualify, you must be 18 to 79 years of age with a diagnosis of Diabetes Type II and not taking insulin more than twice a day (other criteria apply). Complimentary Kidney Function & HBA1C tests are provided to potential study participants to determine eligibility.

Are frequent nightlytrips to the bathroom leaving you exhausted? Nocturia, or frequent urination at night, is a common urological disorder in adults. It typically results in a loss of sleep. Over time, this can lead to fatigue, memory deficits, depression and other issues. In many people the effect of nocturia can compromise their quality of life during daytime hours. Help may be available for people with nocturia. A clinical trial is currently underway to test the effectiveness of a medication to treat nocturia. You may be eligible to participate in this study if you meet the following criteria:

• Are male
• Are age 55 or older
• Have a history of nocturia2-5 voids per night
• Persistent nocturia despite appropriate lifestyle advice (e.g. evening fluid restriction)
• Are generally well

All trial-related visits, testing and study medication or placebo will be provided to participants at no cost. Compensation for time and travel may be available.

Swimmer’s Ear Research Study – You don’t have to be a swimmer to get swimmer’s ear. If you are experiencing pain, itching or swelling of the outer ear, you may have a type of ear infection called acute otitis externa (AOE), also known as swimmer’s ear. While swimmer’s ear is most commonly caused by swimming, it can also occur from the use of hearing aids, headphones (or “earbuds”) and various types of hearing protection. Local doctors in your area are conducting a research study for effectiveness of investigational antibiotic drops for acute otitis externa (AOE). Individuals 6 months of age or older with swimmer’s ear may be eligible to participate.

Cold Sore/Fever Blister Research Study – If you have experienced 3 fever blisters/cold sores on or around the mouth in the last year, you may be eligible to participate in this medical research study evaluating an investigational topical lotion. The study is for those 18 years of age and older who get frequent cold sores and are otherwise healthy. Compensation is available for time and travel if you qualify.

Athlete’s Foot Research Study – If you have been experiencing red, scaly, flaky, and itchy skin between your toes, you might have athlete’s foot, or tinea pedis. Those 18 and older with a suspected case of athlete’s foot might qualify for a research study that evaluates an investigational topical gel as compared to placebo (substance with no medication). The study lasts 6 weeks and has up to 3 office visits and one telephone call, with compensation up to $225.00 for time and travel if you qualify.

Facial Acne Research Study – This acne research study is for those 12 to 40 years of age (those 17 and younger must have a parent/legal guardian to sign consent) who have moderate to severe facial acne. The purpose of this study is to evaluate 2 different study gels versus placebo. Participants have 4 visits over 12 weeks and are compensated up to $300.00 for time and travel.

Melanoma Study – Are you at high risk for recurrence? If so, and you are between the ages of 18 and 75 years old, you may qualify to participate in a clinical research study at Research Across America to determine the safety and effectiveness of an investigational treatment vaccine. Qualified participants will receive at no cost:

Major Depression Study – Are you feeling persistently sad or anxious? Feeling guilty, hopeless, worthless? Have you lost interest in usual activities, including sex? Do you have trouble sleeping or concentrating? If these symptoms of depression persistently interfere with your daily life, you may qualify for a medical research study. This study is for those 18 to 65 years old who have a diagnosis of Major Depressive Disorder. It requires 7 office visits, compensation for time and travel may be available.

Bipolar Type I Research Study – A research study is enrolling those 18 and older with a history of Bipolar Type I for an approved medication for bipolar type 1, to evaluate its effectiveness in treating recurrent acute Manic/Mixed Episodes. Everyone who qualifies to participate receives the study medication at some point during the trial. Psychological evaluations, drug screens and exams are provided at no cost, with compensation of $75 per visit available for time and travel. You may also be eligible for assistance in receiving your anti-psychotic medication immediately following the study, if all requirements of the study are followed.

ADHD Research Study – Is your child aged 13-17 diagnosed with ADHD? You may be eligible to participate in a research study of an investigational medication. Symptoms of ADHD include difficulty remembering information, difficulty concentrating, trouble organizing or completing tasks, and procrastination. Qualified participants may receive study-related psychological evaluation(s) and may also receive compensation for time and travel.

Pediatric Seasonal Allergy Research Study – This study is for children ages 6 to 11 years old who suffer from Seasonal Allergic Rhinitis (SAR) for the last year. The purpose is to evaluate an investigational nasal spray compared to placebo for allergy symptoms. The study could be up to 2 months long and have 5 office visits and one telephone call. Reimbursement for time and travel will be provided for those who qualify.

BPH – Benign Prostatic Hyperplasia Study – This research study is for men ages 45 and over who have had a diagnosis of BPH at least 1 year ago. Symptoms of BPH include night time and frequent urination. The study evaluates an investigational medication that has shown promise in lowering the BPH score. Participants would come to 10 office visits over 1 year and be compensated up to $750.00 for time and travel. Everyone in the trial who wants to will receive the investigational drug either during the trial or at the end of it.

Influenza Research Study – At the first sign of flu symptoms, you may qualify for a medical research study evaluating an investigational medication for flu symptoms. You must be experiencing a fever of at least 100.4 and be experiencing flu symptoms (for example: nasal congestion, coughing, sneezing, chills, fatigue). The study requires 4 office visits over 28 days. Compensation up to $240 is available for time and travel.